ミシガン州におけるアルツハイマー病の臨床試験
ミシガン州内の拠点で、アルツハイマー病に関する15件の研究が参加者を募集しています。
ミシガン州内の都市
公式研究テキスト（英語）
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1620, Troy
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/28更新 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Quest Research Institute, Farmington Hills
被験者募集中第4相
50歳以上 · 全性別 · 2026/09/25更新 · NCT07633470A Study of LY3439539 in Participants With Alzheimer's Disease
- QUEST Research Institute, Farmington Hills
被験者募集中第1相
50歳〜85歳 · 全性別 · 2026/09/24更新 · NCT07598370A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- QUEST Research Institute, Farmington Hills
被験者募集中第2相
55歳〜85歳 · 全性別 · 2026/09/22更新 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Neurobehavioral Medicine Group (NBMG), Bloomfield Township
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/22更新 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Quest Research Institute, Farmington Hills
被験者募集中第3相
50歳〜90歳 · 全性別 · 2026/09/21更新 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- QUEST Research Institute, Farmington Hills
被験者募集中第3相
60歳〜85歳 · 全性別 · 2026/09/17更新 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- NeuroBehavioral Medicine Group, Bloomfield Hills
- Oakland Medical Research, Troy
被験者募集中第3相
55歳〜90歳 · 全性別 · 2026/09/16更新 · NCT07011732Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Michigan Medicine, Ann Arbor
被験者募集中
70歳以上 · 全性別 · 2026/09/08更新 · NCT05929703Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0088, Sterling Heights
被験者募集中第2相
55歳〜90歳 · 全性別 · 2026/09/01更新 · NCT06808984Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Henry Ford Health System, Detroit
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/04更新 · NCT06563895Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial
- Shiawasee Health Department, Corunna
- McLaren Flint OB-GYN, Flint
- Munson Gaylord OB-GYN, Gaylord
- 他5件
被験者募集中
18歳以上 · 女性 · 2026/07/24更新 · NCT07213284A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Revival Research Institute, LLC, Southfield
被験者募集中第3相
55歳以上 · 全性別 · 2026/07/07更新 · NCT07602582A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- QUEST Research Institute, Farmington Hills
被験者募集中第1相健康なボランティア歓迎
45歳〜85歳 · 全性別 · 2026/06/04更新 · NCT06657768Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Quest Research Institute, Farmington Hills
被験者募集中観察研究健康なボランティア歓迎
60歳〜90歳 · 全性別 · 2026/04/15更新 · NCT06584357ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。